Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.77 USD
-0.07 (-2.46%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.77 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Fundamental Charts
About Free Cash Flow (Quarterly)
The Company's quarterly Free Cash Flow is a measure of financial performance and represents the cash that a company is able to generate after factoring the money required to maintain or expand its asset base. Free cash flow is important because it allows a company to pursue opportunities that enhance shareholder value. Free Cash Flow is net income + plus depreciation and amortization - capital expenditures. A higher number is considered better.